about
Clinical and economic evaluation of modulated electrohyperthermia concurrent to dose-dense temozolomide 21/28 days regimen in the treatment of recurrent glioblastoma: a retrospective analysis of a two-centre German cohort trial with systematic compaFM19G11 inhibits O6 -methylguanine DNA-methyltransferase expression under both hypoxic and normoxic conditions.
P2860
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Dose-dense temozolomide: is it still promising?
@ast
Dose-dense temozolomide: is it still promising?
@en
type
label
Dose-dense temozolomide: is it still promising?
@ast
Dose-dense temozolomide: is it still promising?
@en
prefLabel
Dose-dense temozolomide: is it still promising?
@ast
Dose-dense temozolomide: is it still promising?
@en
P2860
P356
P1476
Dose-dense temozolomide: is it still promising?
@en
P2093
Motoo Nagane
P2860
P356
10.2176/NMC.RA.2014-0277
P5008
P577
2014-12-20T00:00:00Z